Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2016 01:05 ET | Source: CELYAD S.A.

CELYAD S.A.: Announces Positive New Data from its CAR-T NKR-2 Phase I Trial at 2016 ASH Annual Meeting

Celyad Announces Positive New Data from its CAR-T NKR-2 Phase I Trial at 2016 ASH Annual Meeting Strong safety signals, including no cases of cytokine release syndrome, cell-related neurotoxicity,...
December 06, 2016 01:02 ET | Source: CELYAD S.A.

Interview vidéo Christian Homsy Directeur Général de Celyad

COMMUNIQUÉ Paris, le 6 décembre 2016 Interview vidéo Christian Homsy Directeur Général Celyad Celyad (Euronext Bruxelles etParis, et NASDAQ : CYAD), leader dans la découverte et...
December 05, 2016 22:00 ET | Source: BeiGene, LTD.

BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenström’s Macroglobulinemia at the 2016 American Society of Hematology Annual Meeting

WALTHAM, Mass., Dec. 05, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE) a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for...
December 05, 2016 19:30 ET | Source: Agios Pharmaceuticals

Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies

- Overall Response Rate of 38% and Complete Remission Rate of 18% with Patients on Study up to 24.2 Months - - For Relapsed/Refractory Acute Myeloid Leukemia Patients, Overall Response Rate of 33%...
December 05, 2016 18:34 ET | Source: The Eye Doctors

The Eye Doctors Host an Event on December 7 to Celebrate the Launch of Their Men’s Premier Red Bull Eyewear Line

TAMPA, Fla., Dec. 05, 2016 (GLOBE NEWSWIRE) -- The Eye Doctors of Florida are pleased to announce that they will be hosting an end of year trunk show to help celebrate the launch of their premier...
December 05, 2016 14:29 ET | Source: Talyst

Talyst and McFarlane Medical Announce Partnership

KIRKLAND, Wash., Dec. 5, 2016 (GLOBE NEWSWIRE) -- Talyst, a market leader in pharmacy automation and medication management solutions, and McFarlane Medical, a developer, manufacturer and packager of...
December 05, 2016 13:01 ET | Source: Global Blood Therapeutics

Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study

-- PRO designed to establish clinical benefit – -- First time a PRO to be used as a secondary clinical endpoint in a SCD registrational study -- --Company to Host Webcast Today at...
December 05, 2016 12:10 ET | Source: American Health Council

American Health Council Names Janet Allan, PhD, APRN, FAAN to Education Board

NEW YORK, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Dr. Janet Allan, Dean Emeritus at the University of Maryland, Baltimore, has been selected to join the Education Board at the American Health Council....
December 05, 2016 11:30 ET | Source: Cytori Therapeutics

Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial

SAN DIEGO, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) Topline review of early three-year follow-up data from the SCLERADEC I trial shows sustained benefit in...
December 05, 2016 11:15 ET | Source: BeiGene, LTD.

BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia at the 2016 American Society of Hematology Annual Meeting

WALTHAM, Mass, Dec. 05, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE) a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the...